Brazil announces purchase of Monkeypox vaccines

The World Health Organization (WHO) on Saturday (23) declared the monkeypox outbreak in more than sixty countries an emergency of international concern. WHO Director-General Tedros Adhanom Ghebreyesus thus announced the highest alert level that the Geneva-based specialized agency of the United Nations could impose in the event of a health threat.

The rare designation means the WHO now views the outbreak as a significant enough threat to global health that a coordinated international response is needed to prevent the virus from spreading further and potentially escalating into a pandemic.

(WHO Admits Everyone Who Receives a MonkeyPox Vaccine is Part of a “Clinical Trial” to Collect Data on its Effectiveness )

Although the declaration does not impose requirements on national governments, it is an urgent call for action.

According to Bloomberg, “The declaration from Tedros … underscores divisions within the organization over the severity of the threat. The pathogen typically causes flu-like symptoms, followed by a rash that often starts on the face and spreads down the belly. (Bloomberg)

Is Dr. Tedros in conflict of interest, going against a committee of medical doctors and scientists? The WHO is funded by the Gates Foundation. And Bill Gates is the centerfold. He has been pushing for the monkeypox scenario since 2017.

Interestingly, it’s the Real-Time PCR test that the CDC declared invalid for detecting SARS-CoV-2 (effective December 31, 2021), which is now being used to “detect the monkeypox pathogen”.

BRAZIL

Shortly after, Brazil, which has accumulated nearly seven hundred cases of monkeypox in less than two months, announced negotiations to purchase vaccines against the disease.

According to the Brazilian Ministry of Health, the disease is being monitored in the largest country in South America. A committee has been set up to monitor the situation and examine the possibility of producing the vaccine at the Butantan Institute.

The Butantan Institute is a Brazilian biomedical research center located in the Butantã district of São Paulo. It is considered one of the most important scientific centers and has become famous worldwide for its research in snake venoms and vaccines.

The number of confirmed cases of monkeypox has multiplied rapidly since the first case was reported on June 8. Brazilian health authorities determined that the first fifteen cases were “imported” cases, as all patients had previously traveled to other countries, mainly in Europe, where they were believed to have contracted the disease.

To date, cases have been reported in fourteen of Brazil’s twenty-seven states, with the highest number in Sao Paulo, the country’s most populous region.

Of the total of six hundred and ninety-six confirmed cases, five hundred and six were registered in Sao Paulo, where the first autochthonous cases were also detected on June 23.

WHO ADMITS EVERYONE WHO RECEIVES A MONKEYPOX VACCINE IS PART OF A CLINICAL TRIAL

An official from the World Health Organization (WHO) admitted on Saturday that everyone who received the Monkeypox vaccine is considered to be part of a “clinical study” for the purpose of data collecting so that researchers can learn more about the “effectiveness of the vaccine.”

On Saturday, WHO conducted a media briefing with WHO Director-General Tedros Adhanom Ghebreyesus and experts to discuss the Monkeypox outbreak.

Tim Nguyen, the Unit Head of Global Infectious Hazards Preparedness at the World Health Organization Emergency Programme, said that the vaccine efficacy is yet unknown since it has never been used on this scale before.

“I would like to underline one thing that is very important to WHO. We do have uncertainty around the effectiveness of these vaccines because they haven’t been used in this context and in this scale before,” Tim Nguyen stressed.